ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNR vs KEQU // EV/EBITDA & P/E VALUATION

Burning Rock Biotech Limited (NASDAQ) VS. Kewaunee Scientific Corporation (NASDAQ) • 15-METRIC TALLY: BNR 2 — KEQU 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNR VS. KEQU) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNR KEQU SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 74.70% 28.50% +46.20 BNR /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 16.70% -51.70 KEQU /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 6.3x — TIE /valuation <GO>
Free Cash Flow Yield -4.14% 19.20% -23.34 KEQU /fcf-yield <GO>
Operating Margin -10.20% 5.90% -16.10 KEQU /operating-margins <GO>
Net Profit Margin -10.30% 3.40% -13.70 KEQU /net-margins <GO>
Revenue Growth (YoY) 9.20% 17.30% -8.10 KEQU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 3.37 -3.17 KEQU /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 KEQU /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 38.2 49.3 -11.17 KEQU /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 8.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $116.5M $97.0M $19.5M BNR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNR REV KEQU REV BNR GROSS % KEQU GROSS % BNR FCF KEQU FCF
FY 2025 $77.2M $282.0M 74.7% 28.5% -$4.8M $18.6M
FY 2024 $70.7M $240.5M 70.3% 28.6% -$13.4M $14.8M
FY 2023 $75.7M $203.8M — — -$36.0M $19.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNR // BETA —
KEQU // BETA —